Dr Ugur Sahin discussed the versatility of his mRNA-based technology
Codex Codex
2.27K subscribers
12,874 views
0

 Published On Nov 22, 2020

At the World's Top 50 Innovators Conference 2019, in response to a question from the audience, Dr Ugur Sahin, CEO of BioNtech, explains how his technology could be applied not only to cancer but also infectious diseases and autoimmune conditions. His full Codex Talk can be viewed here    • Individualized Cancer Immunotherapy -...  

#T50 #BioNTech #Coronavirus #vaccine #covid19 #mRNA#Top50Innovators #CodexTalks #Immunotherapy

show more

Share/Embed